• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童脑癌的蛋白质基因组学

Proteogenomics for pediatric brain cancer.

作者信息

Simonian Margaret

机构信息

University of Californian Los Angeles, David Geffen School of Medicine, Los Angeles, 90095, USA.

出版信息

Biocell. 2021;45(6):1459-1463. Epub 2021 Sep 1.

PMID:35002040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8740781/
Abstract

Pediatric central nervous system tumors are the most common tumors in children, it constitute 15%-20% of all malignancies in children and are the leading cause of cancer related deaths in children. Proteogenomics is an emerging field of biological research that utilizes a combination of proteomics, genomics, and transcriptomics to aid in the discovery and identification of biomarkers for diagnosis and therapeutic purposes. Integrative proteogenomics analysis of pediatric tumors identified underlying biological processes and potential treatments as well as the functional effects of somatic mutations and copy number variation driving tumorigenesis.

摘要

小儿中枢神经系统肿瘤是儿童最常见的肿瘤,占儿童所有恶性肿瘤的15%-20%,是儿童癌症相关死亡的主要原因。蛋白质基因组学是生物研究中一个新兴领域,它结合了蛋白质组学、基因组学和转录组学,以辅助发现和鉴定用于诊断和治疗目的的生物标志物。对小儿肿瘤进行综合蛋白质基因组学分析,确定了潜在的生物学过程和潜在治疗方法,以及驱动肿瘤发生的体细胞突变和拷贝数变异的功能影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cafc/8740781/1afa7358d8d8/nihms-1737905-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cafc/8740781/a0687fef58df/nihms-1737905-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cafc/8740781/1afa7358d8d8/nihms-1737905-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cafc/8740781/a0687fef58df/nihms-1737905-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cafc/8740781/1afa7358d8d8/nihms-1737905-f0002.jpg

相似文献

1
Proteogenomics for pediatric brain cancer.儿童脑癌的蛋白质基因组学
Biocell. 2021;45(6):1459-1463. Epub 2021 Sep 1.
2
Cancer proteogenomics: current impact and future prospects.癌症蛋白质基因组学:当前影响与未来展望。
Nat Rev Cancer. 2022 May;22(5):298-313. doi: 10.1038/s41568-022-00446-5. Epub 2022 Mar 2.
3
Proteogenomic interrogation of cancer cell lines: an overview of the field.肿瘤细胞系的蛋白质基因组学研究:该领域概述。
Expert Rev Proteomics. 2021 Mar;18(3):221-232. doi: 10.1080/14789450.2021.1914594. Epub 2021 Apr 20.
4
Current status of clinical proteogenomics in lung cancer.肺癌临床蛋白质基因组学的现状。
Expert Rev Proteomics. 2019 Sep;16(9):761-772. doi: 10.1080/14789450.2019.1654861. Epub 2019 Aug 21.
5
The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach.寻找新型神经系统疾病生物标志物候选物的挑战:利用蛋白质基因组学方法的机会。
J Mol Neurosci. 2019 Jan;67(1):150-164. doi: 10.1007/s12031-018-1220-1. Epub 2018 Dec 15.
6
Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.蛋白质基因组学:临床发现与个性化医疗的关键驱动力
Adv Exp Med Biol. 2016;926:21-47. doi: 10.1007/978-3-319-42316-6_3.
7
Pediatric brain tumors: Update of proteome-based studies.小儿脑肿瘤:基于蛋白质组的研究进展。
J Proteomics. 2018 Sep 30;188:41-45. doi: 10.1016/j.jprot.2018.02.016. Epub 2018 Feb 19.
8
Clinical implications of recent advances in proteogenomics.蛋白质基因组学最新进展的临床意义
Expert Rev Proteomics. 2016;13(2):185-99. doi: 10.1586/14789450.2016.1132169. Epub 2016 Jan 13.
9
Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.肝细胞癌的蛋白质组学分析与转化前景:通过肿瘤蛋白质基因组学方法鉴定诊断性蛋白质生物标志物。
Kaohsiung J Med Sci. 2016 Nov;32(11):535-544. doi: 10.1016/j.kjms.2016.09.002. Epub 2016 Nov 4.
10
Proteogenomics from a bioinformatics angle: A growing field.从生物信息学角度看蛋白质基因组学:一个不断发展的领域。
Mass Spectrom Rev. 2017 Sep;36(5):584-599. doi: 10.1002/mas.21483. Epub 2015 Dec 15.

本文引用的文献

1
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.小儿脑癌主要组织学类型的综合蛋白质基因组学特征分析
Cell. 2020 Dec 23;183(7):1962-1985.e31. doi: 10.1016/j.cell.2020.10.044. Epub 2020 Nov 25.
2
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.乳腺癌发生和靶向治疗的蛋白质基因组全景分析
Cell. 2020 Nov 25;183(5):1436-1456.e31. doi: 10.1016/j.cell.2020.10.036. Epub 2020 Nov 18.
3
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.基于基因组与蛋白质组联合分析的肺腺癌治疗靶点研究
Cell. 2020 Jul 9;182(1):200-225.e35. doi: 10.1016/j.cell.2020.06.013.
4
Modern Radiotherapy for Pediatric Brain Tumors.小儿脑肿瘤的现代放射治疗
Cancers (Basel). 2020 Jun 11;12(6):1533. doi: 10.3390/cancers12061533.
5
Proteogenomic Characterization of Endometrial Carcinoma.子宫内膜癌的蛋白质基因组学特征分析。
Cell. 2020 Feb 20;180(4):729-748.e26. doi: 10.1016/j.cell.2020.01.026. Epub 2020 Feb 13.
6
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的综合蛋白质基因组特征分析。
Cell. 2019 Oct 31;179(4):964-983.e31. doi: 10.1016/j.cell.2019.10.007.
7
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.HBV 相关肝细胞癌的综合蛋白质基因组特征分析。
Cell. 2019 Oct 3;179(2):561-577.e22. doi: 10.1016/j.cell.2019.08.052.
8
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.人类结肠癌的蛋白质基因组分析揭示了新的治疗机会。
Cell. 2019 May 2;177(4):1035-1049.e19. doi: 10.1016/j.cell.2019.03.030. Epub 2019 Apr 25.
9
The genomic landscape of pediatric cancers: Implications for diagnosis and treatment.儿科癌症的基因组景观:对诊断和治疗的影响。
Science. 2019 Mar 15;363(6432):1170-1175. doi: 10.1126/science.aaw3535.
10
Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.贝伐珠单抗作为单一药物或联合传统化疗方案治疗不可切除或进展性低级别脑胶质瘤患儿。
Cancer Med. 2019 Jan;8(1):40-50. doi: 10.1002/cam4.1799. Epub 2018 Dec 19.